Milestone Pharmaceuticals Inc.
- MIST
- NASDAQ
- Biotechnology
- Cardiovascular Drugs
- Channel Blocker (Etripamil)
- Clinical-Stage Biopharma
$0.70
Today −0.93%Quote Oct 19, 2026, 01:54 PM UTC
−23.09%over the last month
Max drawdown −23.2%From 1-month high −23.2%3 months −40.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$87.2M
Quote Oct 19
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$3.00
+328.1% from here
Floor
$0.65
7.3% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MISTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
38
Founded
2003